創傷管理の先端技術市場

REPORT HIGHLIGHTS The total U.S. market for advanced wound care was estimated at more than $1.7 billion in 2003 and is expected to rise at an AAGR (average annual growth rate) of 10.2% to $2.8 billion. Biological dressings, surgical sealants, synthetic dressings and other wound healing products account for $1.1 billion and will rise at an AAGR of 7.2%. Wound healing devices, e.g., electrostimulation products, hyperbaric oxygen therapies and vacuum-assisted therapies, account for a smaller portion with $608.2 million in sales but are rising faster at an AAGR of 15%.

Total Advanced Wound Care Market by Selected Segment, 2001-2008 ($ Millions) e = estimated. * Includes biological dressings, surgical sealants, synthetic dressings and others. Source: BCC, Inc.

INTRODUCTION

From antiquity, humanity has explored means of controlling hemorrhage and closing wounds. Egyptian papyri dating back to 2100 B.C. describe how various injuries, including head injuries and fractures, were treated. Early surgeons in India surpassed those of Egypt in their skills in treating fractures and other injuries and in performing plastic surgery. Other records describe epidemics, purulence, fumigation, and wound management. These early concepts of infection and crude methods to combat it seem strange in light of modern scientific knowledge.

Advanced wound care technologies have emerged from the shadows to become, in the last 20 years, significant products in wound treatment. While conventionally made wound care products are considerable and generally less expensive, new products and biotechnological advancements are beginning to revolutionize the wound care market. New technological products are competing in a fast track market that seeks to improve the quality of life for millions of individuals needing both acute and chronic wound care.

This timely BCC study provides an overview of products included in this market, and detailed market analyses and competitive environments. It includes information about significant products, players, issues and trends, and other information affecting the wound care industry. The report supplies the knowledge to adequately view and assess the advanced wound care movement and provide insights into market potentials.

SCOPE OF STUDY

The report contains:

• An overview of products and technologies included in this market
• Identifies markets in five general advanced segments: biological dressings, surgical sealants, synthetic dressings, other wound healing products and wound healing devices
• Use of products and forecasts for the U.S. market through 2008
• Competitive analyses of each segment
• Competitor market share estimates for each market segment for the 2003 base year.

METHODOLOGY

The information for this BCC, Inc. report was obtained through primary and secondary data collection methods. Primary methods included interviews with more than 50 key executives, product managers, clinical specialists and other related key personnel involved in the wound care industry. Secondary methods included published literature, investment reports, company literature, and various business journals that have emphases on wound care and related areas.

Market data for this report pertains to the U.S. market in U.S. dollars at the manufacturer level. The base year of the report is 2003, with historical data provided for 2001 and 2002 and forecast data provided for 2008. Historical, base year, and forecast data are provided for each market segment of the report. Growth rates are determined through a compilation of data, including past trends, future trends, demographics, incidence, mortality, products in research and development, current product growth, etc. Competitor market share estimates are provided for each market segment for the 2003 base year.

TABLE OF CONTENTS

INTRODUCTION

• STUDY GOALS AND OBJECTIVES
• REASONS FOR DOING THE STUDY
• SCOPE AND FORMAT
• METHODOLOGY
• RELATED BCC STUDIES
• ANALYST CREDENTIALS
• BCC ON-LINE SERVICES
• DISCLAIMER

EXECUTIVE SUMMARY

• Summary Table:
  TOTAL U.S. ADVANCED WOUND CARE MARKET BY SELECTED SEGMENT, THROUGH 2008 ($ MILLION)
• Summary Figure:
  TOTAL ADVANCED WOUND CARE MARKET BY SELECTED SEGMENT, 2001-2008 ($ MILLION)

INDUSTRY OVERVIEW

• HISTORICAL WOUND CARE OVERVIEW
  • HISTORICAL WOUND CARE OVERVIEW (CONTINUED)
• TYPES OF WOUNDS AND DEMOGRAPHICS
  • ACUTE WOUNDS
  • SURGICAL WOUNDS/INCISION
  • TRAUMATIC WOUNDS
  • LACERATIONS
  • ABRASIONS
  • CONTUSION
  • CHRONIC WOUNDS
  • PRESSURE ULCERS
    • Contributing Factors
• Table 1 COMMON SITES FOR PRESSURE ULCER DEVELOPMENT
  • Staging
• Table 2 STAGING OF PRESSURE ULCERS
  • VENOUS INSUFFICIENCY ULCERS
  • ARTERIAL ULCERS
  • NEUROPATHIC OR DIABETIC ULCERS
    • Neuropathy
    • Diabetics
  • BURN WOUNDS
    • Classification of Burns
• Table 3 CLASSIFICATION OF BURNS
  • Stages of Burn Healing
  • INCIDENCE OF SELECTED CONDITIONS IN U.S. MARKET
• Table 4 U.S. INCIDENCE AND PREVALENCE OF SELECTED CONDITIONS AFFECTING THE WOUND CARE MARKET
• Figure 1 U.S. INCIDENCE AND PREVALENCE OF SELECTED CONDITIONS AFFECTING THE WOUND CARE MARKET (%)
  • INCIDENCE BY AGE GROUP AND WOUND TYPE
• Table 5 ESTIMATED WOUND INCIDENCE BY AGE GROUP AND TYPE OF WOUND (%)
• Figure 2 ESTIMATED WOUND INCIDENCE BY AGE GROUP AND TYPE OF WOUND (%)
  • AGING U.S. POPULATION
• Table 6 U.S. POPULATION ESTIMATES AND PROJECTIONS, BY AGE GROUP, FOR SPECIFIC YEARS, 1900 TO 2050 (# THOUSAND)
• Figure 3 U.S. POPULATION ESTIMATES AND PROJECTIONS, BY AGE GROUP, FOR SPECIFIC YEARS 1900 TO 2050 (%)
  • FORECAST PERIOD POPULATION PROJECTIONS
• Table 7 ESTIMATED U.S. POPULATION, BY AGE GROUP, 2001-2008 (THOUSAND)
• Figure 4 ESTIMATED U.S. POPULATION, BY AGE GROUP, 2001-2008 (%)
  • GENDER AND AGE
• Table 8 ESTIMATES OF EXPECTED U.S. LIFE EXPECTANCY AT BIRTH AND PROJECTIONS, BY GENDER, 2000-2010 (YEARS)
  • THE PROCESS OF WOUND HEALING
    • HEALING BY PRIMARY INTENTION
      • Inflammatory Phase
      • Destructive Phase
      • Proliferative Phase
      • Maturation
    • HEALING BY SECONDARY INTENTION
    • FACTORS AFFECTING WOUND HEALING
      • General Health
      • Smoking
      • Age
      • Nutritional Status
      • Obesity
      • Fluid and Electrolyte Balance
      • Immunosuppressed or Compromised Individuals
    • DRUGS
      • Radiation Therapy
    • NUTRITION IN WOUND HEALING
    • COMPLICATIONS OF WOUND HEALING
      • Scarring
      • Adhesions
      • Dehiscence
      • Evisceration
      • Infection
      • Hemorrhage
      • Fistulas
      • Infection
  • ECONOMIC IMPACT OF WOUNDS AND WOUND MANAGEMENT

ISSUES AFFECTING THE MARKET

• REIMBURSEMENT ISSUES
• HIGH-TECH BANDAGES
• BATTLEFIELD WOUND CARE
  • BATTLEFIELD WOUND CARE (CONTINUED)
• IN VITRO VERSUS IN VIVO
  • IN VITRO
  • IN VIVO
• Table 9 ADVANTAGES OF IN VIVO AND IN VITRO TISSUE GROWTH
  • FUTURE RESEARCH
    • STEM CELL RESEARCH
    • GENE THERAPY
    • LIGHT-EMITTING DIODES

TECHNOLOGY

• CURRENT USES OF TECHNOLOGY
  • TISSUE-ENGINEERED SKIN SUBSTITUTES
  • SKIN REGENERATION MATRICES
• TECHNOLOGY PATENT ANALYSIS
  • PATENTS ISSUED 1998 TO 2004
• Table 10 U.S. PATENT EVALUATION FOR MAJOR WOUND-CARE RELATED TECHNOLOGY BY ISSUE DATE
• Table 10 (CONTINUED)
• Table 10 (CONTINUED)
• Table 10 (CONTINUED)
• Table 10 (CONTINUED)
  • COMPANY SHARES OF PATENTS
• Table 11 U.S. PATENT EVALUATION FOR ADVANCED WOUND CARE RELATED TECHNOLOGY BY NUMBER OF PATENTS PER PATENT HOLDER
• Table 11 (CONTINUED)
  • BIOTHERAPEUTICS
    • BIOTHERAPEUTICS (CONTINUED)

BIOLOGICAL DRESSINGS

• OVERVIEW
• PRODUCT DESCRIPTION
  • ARTIFICIAL SKIN/SKIN REPLACEMENT
    • AlloDerm
    • Apligraf
    • Dermagraft
    • Epicel
    • OrCel
    • TransCyte
• OTHER BIOLOGIC THERAPIES
  • COLLAGEN
    • Matrix Collagen Particles
    • GraftJacket
    • DressSkin
    • Promogran
  • GROWTH FACTORS
• Table 12 MANUFACTURERS OF BIOLOGIC DRESSINGS 2003
  • IN DEVELOPMENT
• Table 13 BIOLOGIC PRODUCTS IN DEVELOPMENT
  • MARKET ANALYSIS AND CONCLUSIONS
    • ESTIMATED MARKET BY SEGMENT
• Table 14 ESTIMATED U.S. MARKET FOR BIOLOGICAL DRESSINGS BY PRODUCT SEGMENT, THROUGH 2008 ($ MILLION)
  • ESTIMATED MARKET BY WOUND TYPE
• Table 15 ESTIMATED U.S. MARKET FOR BIOLOGICAL DRESSINGS BY WOUND TYPE, THROUGH 2008 ($ MILLION)
  • COMPETITIVE SUMMARY
• Table 16 COMPETITIVE SUMMARY FOR BIOLOGICAL DRESSINGS BY COMPETITORS REVENUES, 2003 ($ MILLION)
• Figure 5 COMPETITIVE SUMMARY FOR BIOLOGICAL DRESSINGS BY COMPETITORS REVENUES, 2003 (%)

SURGICAL SEALANTS AND GLUES

• OVERVIEW
• PRODUCT DESCRIPTIONS
  • ANGIO-SEAL
  • BIOGLUE
  • DERMABOND
  • FLOSEAL
  • HEMASEEL
  • LIQUISHIELD
  • PERCLOSE
  • TISSEEL
  • VASOSEAL
• Table 17 MANUFACTURERS OF BIOLOGIC DRESSINGS 2003
  • IN DEVELOPMENT
    • VASCULAR SEALANT
• Table 18 VASCULAR SEALANT PRODUCTS IN DEVELOPMENT
  • MARKET ANALYSIS AND CONCLUSIONS
• Table 19 ESTIMATED U.S. MARKET FOR SURGICAL SEALANTS AND GLUES, THROUGH 2008 ($ MILLION)
  • COMPETITIVE SUMMARY
• Table 20 COMPETITIVE SUMMARY FOR SURGICAL SEALANTS AND GLUES BY COMPETITOR REVENUES, 2003 ($ MILLION)
• Figure 6 COMPETITIVE SUMMARY FOR SURGICAL SEALANTS AND GLUES BY COMPETITOR REVENUES, 2003 (%)

SYNTHETIC DRESSINGS

• OVERVIEW
• PRODUCT DESCRIPTION
  • ALGINATE DRESSINGS
• Table 21 MANUFACTURERS OF ALGINATE DRESSINGS 2003
  • AlgiSite M
  • Algosteril
  • Curasorb
  • Dermastat
  • Fybron
  • Kalginate
  • Kaltostat
  • Sorbsan
  • Tegagen
  • FILM DRESSINGS
• Table 22 MANUFACTURERS OF FILM DRESSINGS 2003
  • Arglaes
  • Bioclusive
  • Carrafilm
  • Mepore Pro
  • OpSite
  • PolySkin
  • Silvasorb
  • Tegaderm
  • Transeal
  • FOAM DRESSINGS
• Table 23 MANUFACTURERS OF FOAM DRESSINGS 2003
  • Allevyn
  • Biatain
  • Biopatch
  • Carrasmart
  • Flexzan
  • Lyofoam
  • Mepilex
  • Osmocyte
  • Acticoat
  • Polyderm
  • Reston
  • HYDROCOLLOID DRESSINGS
• Table 24 MANUFACTURERS OF HYDROCOLLOID DRESSINGS 2003
  • Combiderm
  • Comfeel
  • Dermatell
  • Duoderm
  • Hyperion
  • Hydrocol
  • Nu-Derm
  • Procol
  • Replicare
  • Sorbex
  • Tegasorb
  • HYDROGEL DRESSINGS
• Table 25 MANUFACTURERS OF HYDROGEL DRESSINGS 2003
  • Acryderm
  • Biolex
  • Clearsite
  • Curafil
  • Flexigel
  • Intrasite
  • Nu-Gel
  • Purilon
  • Tegagel
  • TransiGel
  • MARKET ANALYSIS AND CONCLUSION
• Table 26 ESTIMATED U.S. MARKET FOR SYNTHETIC DRESSINGS BY PRODUCT SEGMENT, THROUGH 2008 ($ MILLION)
• Table 27 ESTIMATED MARKET FOR SYNTHETIC DRESSINGS BY WOUND TYPE, THROUGH 2008 ($ MILLION)
  • COMPETITIVE SUMMARY
• Table 28 COMPETITIVE SUMMARY FOR SYNTHETIC DRESSINGS BY COMPETITOR REVENUES, 2003 ($ MILLION)
• Figure 7 COMPETITIVE SUMMARY FOR MAJOR SYNTHETIC DRESSING COMPETITORS BY REVENUE, 2003 (%)

OTHER WOUND HEALING PRODUCTS

• OVERVIEW
• PRODUCT DESCRIPTION
  • ADCON
  • FLOGEL
  • INTERCEED
  • IONIC
  • SEPRAFILM
• Table 29 MANUFACTURERS OF OTHER ADVANCED WOUND CARE DRESSINGS, 2003
  • PROACT
  • MARKET ANALYSIS AND CONCLUSIONS
• Table 30 ESTIMATED U.S. MARKET FOR OTHER WOUND HEALING PRODUCTS, THROUGH 2008 ($ MILLION)
  • COMPETITIVE SUMMARY
• Table 31 COMPETITIVE SUMMARY FOR OTHER WOUND HEALING PRODUCTS BY COMPETITORS REVENUES, 2003 ($ MILLION)
• Figure 8 COMPETITIVE SUMMARY FOR OTHER WOUND HEALING PRODUCTS BY COMPETITORS REVENUES, 2003 ($ MILLION)

WOUND HEALING DEVICES

• OVERVIEW
• PRODUCT DESCRIPTION
  • ELECTRICAL STIMULATION DEVICES
  • HYPERBARIC OXYGEN DEVICES
  • OTHER DEVICES
    • V.A.C. (Vacuum Assisted Closure)
    • Radio Frequency Stimulus
    • Warm-Up Active Wound Therapy
    • External Tissue Expander (Proxiderm)
• MARKET ANALYSIS AND CONCLUSION
• Table 32 ESTIMATED U.S. MARKET FOR WOUND HEALING DEVICES BY PRODUCT SEGMENT, THROUGH 2008 ($ MILLION)
  • COMPETITIVE SUMMARY
• Table 33 COMPETITIVE SUMMARY FOR WOUND HEALING DEVICES BY COMPETITOR REVENUES, 2003 ($ MILLION)
• Figure 9 COMPETITIVE SUMMARY FOR WOUND HEALING DEVICES BY COMPETITOR REVENUES, 2003 (%)
  • PRODUCT COST ANALYSIS
• Table 34 PRODUCT COST ANALYSIS BY PRODUCT AND MANUFACTURER ($)

MARKET SUMMARY

• TOTAL ADVANCED WOUND CARE MARKET ANALYSIS
• Table 35 TOTAL U.S. MARKET REVENUE ANALYSIS FOR ADVANCED WOUND CARE BY PRODUCT TYPE, THROUGH 2008 ($ MILLION)
• Figure 10 TOTAL U.S. MARKET ANALYSIS FOR ADVANCED WOUND CARE BY PRODUCT TYPE, 2001-2008 ($ MILLION)
• Table 36 TOTAL U.S. MARKET ANALYSIS FOR ADVANCED WOUND CARE BY WOUND TYPE, THROUGH 2008 ($ MILLION)
• Figure 11 TOTAL U.S. MARKET ANALYSIS FOR ADVANCED WOUND CARE BY WOUND TYPE, 2001-2008 ($ MILLION)
  • INDUSTRY PARTICIPANTS BY TYPE
• Table 37 MAJOR INDUSTRY PARTICIPANTS BY PRODUCT TYPE
• Table 37 (CONTINUED)
• Figure 12 DISTRIBUTION OF MAJOR INDUSTRY PARTICIPANTS BY PRODUCT SEGMENT PARTICIPATION (%)
• Figure 12 (CONTINUED)
  • COMPETITIVE ANALYSIS
• Table 38 TOTAL COMPETITIVE MARKET SHARE FOR ADVANCED WOUND CARE BY MANUFACTURERS REVENUES, 2003 ($ MILLION)
• Figure 13 TOTAL COMPETITIVE MARKET SHARE FOR ADVANCED WOUND CARE BY MANUFACTURER REVENUES, 2003 (%)

COMPANY PROFILES

• 3M HEALTHCARE
• ABBOTT VASCULAR DEVICES (U.S.)
• BAXTER INTERNATIONAL
• CLOSURE MEDICAL CORP.
• COLOPLAST A/S
• CONVATEC, LTD.
• ETHICON, INC.
• GENZYME BIOSURGERY
• KINETIC CONCEPTS, INC.
• SMITH & NEPHEW PLC
• ST. JUDE MEDICAL

APPENDIX

• Figure 14 COMPARITIVE MARKET PENETRATION OF LEADING AND AFFILIATED ADVANCED WOUND CARE TECHNOLOGY COMPANIES ($ MILLIONS
  • LEADING MANUFACTURERS
    • LEADING MANUFACTURERS (CONTINUED)
  • AFFILIATED COMPANIES
    • AFFILIATED COMPANIES (CONTINUED)
    • AFFILIATED COMPANIES (CONTINUED)
    • AFFILIATED COMPANIES (CONTINUED)
    • AFFILIATED COMPANIES (CONTINUED)
    • AFFILIATED COMPANIES (CONTINUED)
    • AFFILIATED COMPANIES (CONTINUED)
    • AFFILIATED COMPANIES (CONTINUED)

LIST OF TABLES

Summary Table:
TOTAL U.S. ADVANCED WOUND CARE MARKET BY SELECTED SEGMENT, THROUGH 2008 ($ MILLION)

Table 1 COMMON SITES FOR PRESSURE ULCER DEVELOPMENT

Table 2 STAGING OF PRESSURE ULCERS

Table 3 CLASSIFICATION OF BURNS

Table 4 U.S. INCIDENCE AND PREVALENCE OF SELECTED CONDITIONS AFFECTING THE WOUND CARE MARKET

Table 5 ESTIMATED WOUND INCIDENCE BY AGE GROUP AND TYPE OF WOUND (%)

Table 6 U.S. POPULATION ESTIMATES AND PROJECTIONS, BY AGE GROUP, FOR SPECIFIC YEARS, 1900 TO 2050 (# THOUSAND)

Table 7 ESTIMATED U.S. POPULATION, BY AGE GROUP, 2001-2008 (THOUSAND)

Table 8 ESTIMATES OF EXPECTED U.S. LIFE EXPECTANCY AT BIRTH AND PROJECTIONS, BY GENDER, 2000-2010 (YEARS)

Table 9 ADVANTAGES OF IN VIVO AND IN VITRO TISSUE GROWTH

Table 10 U.S. PATENT EVALUATION FOR MAJOR WOUND-CARE RELATED TECHNOLOGY BY ISSUE DATE

Table 11 U.S. PATENT EVALUATION FOR ADVANCED WOUND CARE RELATED TECHNOLOGY BY NUMBER OF PATENTS PER PATENT HOLDER

Table 12 MANUFACTURERS OF BIOLOGIC DRESSINGS 2003

Table 13 BIOLOGIC PRODUCTS IN DEVELOPMENT

Table 14 ESTIMATED U.S. MARKET FOR BIOLOGICAL DRESSINGS BY PRODUCT SEGMENT, THROUGH 2008 ($ MILLION)

Table 15 ESTIMATED U.S. MARKET FOR BIOLOGICAL DRESSINGS BY WOUND TYPE, THROUGH 2008 ($ MILLION)

Table 16 COMPETITIVE SUMMARY FOR BIOLOGICAL DRESSINGS BY COMPETITORS REVENUES, 2003 ($ MILLION)

Table 17 MANUFACTURERS OF BIOLOGIC DRESSINGS 2003

Table 18 VASCULAR SEALANT PRODUCTS IN DEVELOPMENT

Table 19 ESTIMATED U.S. MARKET FOR SURGICAL SEALANTS AND GLUES, THROUGH 2008 ($ MILLION)

Table 20 COMPETITIVE SUMMARY FOR SURGICAL SEALANTS AND GLUES BY COMPETITOR REVENUES, 2003 ($ MILLION)

Table 21 MANUFACTURERS OF ALGINATE DRESSINGS 2003

Table 22 MANUFACTURERS OF FILM DRESSINGS 2003

Table 23 MANUFACTURERS OF FOAM DRESSINGS 2003

Table 24 MANUFACTURERS OF HYDROCOLLOID DRESSINGS 2003

Table 25 MANUFACTURERS OF HYDROGEL DRESSINGS 2003

Table 26 ESTIMATED U.S. MARKET FOR SYNTHETIC DRESSINGS BY PRODUCT SEGMENT, THROUGH 2008 ($ MILLION)

Table 27 ESTIMATED MARKET FOR SYNTHETIC DRESSINGS BY WOUND TYPE, THROUGH 2008 ($ MILLION)

Table 28 COMPETITIVE SUMMARY FOR SYNTHETIC DRESSINGS BY COMPETITOR REVENUES, 2003 ($ MILLION)

Table 29 MANUFACTURERS OF OTHER ADVANCED WOUND CARE DRESSINGS, 2003

Table 30 ESTIMATED U.S. MARKET FOR OTHER WOUND HEALING PRODUCTS, THROUGH 2008 ($ MILLION)

Table 31 COMPETITIVE SUMMARY FOR OTHER WOUND HEALING PRODUCTS BY COMPETITORS REVENUES, 2003 ($ MILLION)

Table 32 ESTIMATED U.S. MARKET FOR WOUND HEALING DEVICES BY PRODUCT SEGMENT, THROUGH 2008 ($ MILLION)

Table 33 COMPETITIVE SUMMARY FOR WOUND HEALING DEVICES BY COMPETITOR REVENUES, 2003 ($ MILLION)

Table 34 PRODUCT COST ANALYSIS BY PRODUCT AND MANUFACTURER ($)

Table 35 TOTAL U.S. MARKET REVENUE ANALYSIS FOR ADVANCED WOUND CARE BY PRODUCT TYPE, THROUGH 2008 ($ MILLION)

Table 36 TOTAL U.S. MARKET ANALYSIS FOR ADVANCED WOUND CARE BY WOUND TYPE, THROUGH 2008 ($ MILLION)

Table 37 MAJOR INDUSTRY PARTICIPANTS BY PRODUCT TYPE

Table 38 TOTAL COMPETITIVE MARKET SHARE FOR ADVANCED WOUND CARE BY MANUFACTURERS REVENUES, 2003 ($ MILLION)  

LIST OF FIGURES

Summary Figure:
TOTAL ADVANCED WOUND CARE MARKET BY SELECTED SEGMENT, 2001-2008 ($ MILLION)

Figure 1 U.S. INCIDENCE AND PREVALENCE OF SELECTED CONDITIONS AFFECTING THE WOUND CARE MARKET (%)

Figure 2 ESTIMATED WOUND INCIDENCE BY AGE GROUP AND TYPE OF WOUND (%)

Figure 3 U.S. POPULATION ESTIMATES AND PROJECTIONS, BY AGE GROUP, FOR SPECIFIC YEARS 1900 TO 2050 (%)

Figure 4 ESTIMATED U.S. POPULATION, BY AGE GROUP, 2001-2008 (%)

Figure 5 COMPETITIVE SUMMARY FOR BIOLOGICAL DRESSINGS BY COMPETITORS REVENUES, 2003 (%)

Figure 6 COMPETITIVE SUMMARY FOR SURGICAL SEALANTS AND GLUES BY COMPETITOR REVENUES, 2003 (%)

Figure 7 COMPETITIVE SUMMARY FOR MAJOR SYNTHETIC DRESSING COMPETITORS BY REVENUE, 2003 (%)

Figure 8 COMPETITIVE SUMMARY FOR OTHER WOUND HEALING PRODUCTS BY COMPETITORS REVENUES, 2003 ($ MILLION)

Figure 9 COMPETITIVE SUMMARY FOR WOUND HEALING DEVICES BY COMPETITOR REVENUES, 2003 (%)

Figure 10 TOTAL U.S. MARKET ANALYSIS FOR ADVANCED WOUND CARE BY PRODUCT TYPE, 2001-2008 ($ MILLION)

Figure 11 TOTAL U.S. MARKET ANALYSIS FOR ADVANCED WOUND CARE BY WOUND TYPE, 2001-2008 ($ MILLION)

Figure 12 DISTRIBUTION OF MAJOR INDUSTRY PARTICIPANTS BY PRODUCT SEGMENT PARTICIPATION (%)

Figure 13 TOTAL COMPETITIVE MARKET SHARE FOR ADVANCED WOUND CARE BY MANUFACTURER REVENUES, 2003 (%)

Figure 14 COMPARITIVE MARKET PENETRATION OF LEADING AND AFFILIATED ADVANCED WOUND CARE TECHNOLOGY COMPANIES ($ MILLIONS